|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Efavirenz (CAS 143491-57-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Emtricitabine(FTC) (CAS 143491-57-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). XOMA Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... s bacterial cell expression technology. RAPTIVA (efalizumab) with Genentech, Inc. (Genentech): RAPTIVA ... Global Biosimilar Lymphocyte Modulator Market Growth (Status and Outlook) 2023-2029 ... : Segmentation by type Campath-1H Natalizumab Biosimilar Efalizumab-A1089-Anti-CD11a Bisoimilar Anti ... Global Biosimilar Lymphocyte Modulator Market 2022 by Company, Regions, Type and Application, Forecast to 2028 ... by Type, covers Campath-1H Natalizumab Biosimilar Efalizumab-A1089-Anti-CD11a Bisoimilar Anti ... Psoriasis Drugs: Market Research Report This report analyzes the worldwide markets for Psoriasis Drugs in US$ Million by the following Drug Administration Routes - Systemic Drugs, and Topical Drugs. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World ... Global Biosimilar Lymphocyte Modulator Market Research Report 2024(Status and Outlook) ... Segmentation (by Type) Campath-1H Natalizumab Biosimilar Efalizumab-A1089-Anti-CD11a Bisoimilar Anti ... |